|Day Low/High||133.00 / 142.99|
|52 Wk Low/High||90.14 / 179.65|
Wall Street is looking at a quieter coming week with just a trickle of economic data to analyze before the Federal Reserve meeting on Dec. 13-14.
The British-based pharmaceutical company offers one of the best plays for investing in the growing legal marijuana industry.
The U.S. president elect has said in the past that he favors the legalization of marijuana, and he is unlikely to change his stance significantly.
Volatility in the stock markets should not be feared by investors, because any large gains or losses are often reversed after the panic or euphoria subsides.
Cannabis stocks listed on the Nasdaq continued to rally after voters ended prohibition and approved the recreational use of marijuana in California, Massachusetts, Maine and Nevada.
The volume of cannabis stocks listed on the Nasdaq have spiked ahead of the election as voters decide tomorrow on recreational and medical use of marijuana.
Jim Cramer says JCP is better, but 'just OK,' and investors should be careful with CEMP.
Jim Cramer says the market can have many winners.
Legalization of marijuana for medical reasons or otherwise is already on the ballot in Arkansas, California, North Dakota and several other states.
Marijuana is on the ballot in several states this election cycle, and its approval could be a boon for those in the business -- though obstacles remain.
Shares of these cannabis companies are ready for huge growth if November is a successful month for legalization.
The company's share price has increased 1,500% since 2013.
But the buyers are still unable to produce sustained momentum.
Analysts are predicting that the legal pot market could reach $6.7 billion in sales this year.
Investors shouldn't give up on Gilead's Hep. C drug, Cramer says.
GW Pharma could be the answer to an opiate addiction that isn't understood.
Cramer continues to back Apple and says Align Technology is a stock to buy now.
Investors hate uncertainty, Cramer says, but uncertainty creates bargains.
Stocks hold near session lows by mid-afternoon Monday as Wall Street grows restless ahead of the first presidential debate.
GW Pharmaceuticals (GWPH) said on Monday its seizure drug epidiolex had positive results in a late-stage clinical trial.
Cramer is sticking with International Paper and likes Advanced Micro Devices.
This is not the time to sell in a panic, Cramer says.
The marijuana market is heating up as marijuana usage for medical and recreational purposes gains legitimacy.
GW Pharmaceuticals (GWPH) reportedly hired Morgan Stanley after it was approached by several companies about a possible takeover.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.